MENU
APM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Aptorum Group (APM) Ownership - Who owns Aptorum Group?
Aptorum Group Ltd clinical-stage biopharmaceutical company... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
17 Hanover Square
Phone
+44 2080929299
Employees
19
Web
https://www.aptorumgroup.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.52M
P/E Ratio
3.10
Total Cash
2.01M
Projected Growth
N/A
Total Debt
3.28M
Revenue
431.38K
Risk (Beta)
0.08
Dividend Yield
N/A
Total Cash/Share
0.28
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
APM
Capitalization
6.52M
P/E Ratio
3.10
Risk (Beta)
0.08
Dividend Yield
N/A
Total Cash
2.01M
Total Cash/Share
0.28
Total Debt
3.28M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
431K
ROE
N/A
Book Value
24.8M
P/B Ratio
0.30
Cash Flow
N/A
Earnings
-0.62
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
53
Current Ratio
1.18
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-9.6M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-13.61
Shares Held By Institutions
134K
Shares Outstanding - Current
7.14M
Total Liabilities
5.26M
Total Volume MTD
N/A
Value
1
Gain YTD
-65.714
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutic and diagnostic products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
17 Hanover Square
Phone
+44 2080929299
Employees
19
Web
https://www.aptorumgroup.com